About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
HZNP - Horizon Pharma plc| Previous Close | $90.57 | Open | $91.83 |
| Volume | 3.13M | Market Cap | 19.99B |
| Yield | Last Dividend |
| Horizon Therapeutics plc to Present at t... | 02/26/21 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in Marc... | |
| RegeneRx Biopharmaceuticals (OTCMKTS:RGR... | 02/25/21 |
| RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) and Horizon Therapeutics Public (NASDAQ:HZNP) are both medical companies, but which is the better investmen... | |
| Horizon Therapeutics CEO on its record 2... | 02/24/21 |
| CNBC's Melissa Lee discusses Horizon Therapeutics' breakthrough year with Horizon CEO Tim Walbert. | |
| Horizon Therapeutics Public Earnings Rep... | 02/22/21 |
| Horizon Therapeutics Public announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself... | |
| New Survey Assessment Finds Debilitating... | 02/22/21 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced results of a new Thyroid Eye Disease (TED) quality of life assessment presented at the NANOS A... | |
| Dr Reddy's loses bid to invalidate Horiz... | 02/17/21 |
| Indian generic drugmaker Dr Reddy's Laboratories Ltd has lost a bid to invalidate patents on Horizon Therapeutics Plc and Nuvo Pharmaceuticals Inc's a... | |
| Jefferies Stick to Their Buy Rating for ... | 02/17/21 |
| Jefferies Stick to Their Buy Rating for Horizon Therapeutics | |
| This Is What Hedge Funds Bought And Sold... | 02/16/21 |
| This Is What Hedge Funds Bought And Sold In Q4: Complete 13F Summary In the aftermath of late January's massive short squeeze fireworks, 13F reporting... | |
| The Daily Biotech Pulse: European Regula... | 02/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D ... | |
| VIELA BIO INVESTOR ALERT by the Former A... | 02/04/21 |
| NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (???KSF???) a... | |
| Horizon Therapeutics plc Expands Medidat... | 02/04/21 |
| NEW YORK--(BUSINESS WIRE)--Horizon Therapeutics expands partnership with Medidata to speed clinical trial start-up and completion, using a broad range... | |
| Horizon Therapeutics plc to Release Four... | 02/03/21 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its fourth-quarter and full-year 2020 financial results will be ... | |
| Horizon Therapeutics has agreed to buy b... | 02/02/21 |
| Horizon Therapeutics has agreed to buy biotech company Viela Bio for $3 billion, according to an announcement on Feb. 1. Shares of Horizon closed 6.3% | |
| Osteoarthritis Therapeutics Market worth... | 02/02/21 |
| According to the new market research report "Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroid... | |
| Viela Bio Merger Investigation: Halper S... | 02/01/21 |
| NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether Viela Bio, Inc. (NASDAQ: VIE) and its board o... | |
| Horizon Therapeutics To Buy Viela For $3... | 02/01/21 |
| Horizon Therapeutics PLC (NASDAQ: HZNP ), a rare and rheumatic diseases drug company, announced a multibillion-dollar deal Monday to snap up Viela Bio... | |
| AstraZeneca to divest Viela Bio stake | 02/01/21 |
| AstraZeneca has agreed to divest its 26.7% stake in US biotechnology company Viela Bio as part of the latter???s proposed acquisition by Horizon Thera... | |
| Horizon Therapeutics plc to Acquire Viel... | 02/01/21 |
| DUBLIN & GAITHERSBURG, Md.--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) and Viela Bio, Inc. (Nasdaq: VIE) today announced the companies h... | |
| Horizon Therapeutics plc Provides Prelim... | 01/11/21 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced updates on its 2020 financial results, TEPEZZA supply and new KRYSTEX... | |
| Horizon Therapeutics plc Announces Short... | 12/17/20 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced that it expects a short-term disruption in TEPEZZA (teprotumumab-trbw) supp... | |
| Horizon Therapeutics Public Limited (NAS... | 12/16/20 |
| Horizon Therapeutics Public Limited (NASDAQ:HZNP) SVP Miles W. Mchugh sold 1,856 shares of the company???s stock in a transaction on Monday, December ... | |
| San Francisco Bay Area Leaders Extend Su... | 12/02/20 |
| SAN FRANCISCO, Dec. 2, 2020 /PRNewswire/ -- Corporate leaders from Salesforce, Google, PayPal, VISA, BlackRock, Cisco, Adobe, Horizon Therapeutics, KP... | |
| Global Pancreatic Enzyme Replacement The... | 11/27/20 |
| Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled ???Global Pancreatic Enzyme Replacement Therapy Ma... | |
| Halozyme Raises Full Year 2020 Guidance | 11/23/20 |
| SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it is updating 2020 financial guidance to ref... | |
| Horizon Therapeutics plc and Halozyme Th... | 11/23/20 |
| /PRNewswire/ -- Horizon Therapeutics plc (Nasdaq: HZNP) and Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced a global collaboration and lice... | |
| AstraZeneca ??? Nov 22, 2020 ??? Eversep... | 11/22/20 |
| AstraZeneca - Nov 22, 2020 - Eversept Companions, LLC Buys Amarin Corp PLC, Teva Pharmaceutical Industries, Catalent Inc, Sells TG Therapeutics Inc, A... | |
| National Association for Business Resour... | 11/17/20 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) has been named to the National Association for Business Resources??? 2020 list of Bes... | |
| First Thyroid Eye Disease (TED) Awarenes... | 11/16/20 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics Launches First Thyroid Eye Disease (TED) Awareness Week, Nov. 16-20 | |
| New Data Build on Growing Evidence Suppo... | 11/13/20 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced new TEPEZZA?? (teprotumumab-trbw) data presented at the American Academy of Ophthalmology Annu... | |
| Horizon Therapeutics plc CEO Tim Walbert... | 11/13/20 |
| DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Tim Walbert, chairman, president and chief executive officer, ha... | |
| Buy rating | 02/17/21 |
| Jefferies maintains Buy rating and raises Price Target from $103.00 to $120.00 | |
| Date | 2021-02-24 (BMO) | Est. (EPS/Rev.) | $1.05/ 690.03M |
| Actual (EPS/Rev.) | $1.28/ $745.31 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
